NCT03999723 2024-04-17
EVI-3
Rigshospitalet, Denmark
Phase 2 Recruiting
Clinical Trials
4 trialsNCT03397173 2021-08-11
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00184054 2014-07-25
Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia
University of Southern California
Phase 2 Terminated
NCT00329498 2006-10-26
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
Samsung Medical Center
Phase 2 Suspended